Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734667 · ClinicalTrials.gov registry record · NA
Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes
A NA study of Type 1 Diabetes Mellitus, sponsored by Korey Hood.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT02734667: Completed NA study of Type 1 Diabetes Mellitus, sponsored by Korey Hood.
NCT02734667 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Korey Hood. The registered enrollment target is 120 participants, below the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734667, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Korey Hood.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.
Primary Outcome
Increasingly it is recognized that the percent time spent in a target blood glucose range, which is set by the American Diabetes Association, is an important outcome. This measure will be used as a primary outcome and derived from objective data downloads. It is calculated using the values for 14 days around the assessment time point.
Conditions Studied
Interventions
- DEVICE CGM at diagnosis of T1D
Study Locations (2)
California
- Stanford University - Stanford
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-02 |
| Phase | NA |
What the finished NCT02734667 record still lists
NCT02734667 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (30% lower).
The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which CGM at diagnosis of T1D is the first listed.
NCT02734667 reports a single indexed study location in California, Colorado.
Frequently Asked Questions
What is clinical trial NCT02734667 about?
NCT02734667 is a clinical study titled "Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes". The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.
What is the current status of trial NCT02734667?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2016-02. Estimated completion is 2020-02.
What conditions does trial NCT02734667 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT02734667?
The interventions under investigation include: CGM at diagnosis of T1D (DEVICE).
Who is sponsoring clinical trial NCT02734667?
This trial is sponsored by Korey Hood, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02734667 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02734667's enrollment target sits among peer trials
120 27th of 112 higher than 83 of 112 other Type 1 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia